Fig. 1CT observations for case 1. (A) Chest CT scan on admission demonstrated a central lung mass at the level of the carina, with no central enhancement within the mass in the pre-enhance CT. (B) A highly enhancing component within the mass was evident in the enhanced CT, similar in attenuation to that of the major vessels (black arrow).
Fig. 2Contrast-enhanced CT scan performed after the third cycle of combination chemotherapy of docetaxel and cisplatin for case 1. CT revealed a marked decrease in the size of the carinal lesion compared with an earlier study, and no central enhancing component.
Fig. 3CT observations for case 2. (A) Contrast-enhanced CT in the arterial phase revealed a heterogenous mass in the right upper lobe with a strongly enhancing 1.4 cm central area (black arrow). (B) The central enhancement was washed out in the delayed phase, compatible with a pseudoaneurysm of the artery.
Fig. 4Contrast-enhanced CT scan performed after the third cycle of combination chemotherapy of docetaxel and cisplatin for case 2. CT revealed significant decrease in the size of the mass and changed into a cavitary formation without central enhancement.